James Hollingshead Resmed Inc (RSMDF) insider trading activity

James Hollingshead is President, Sleep Business of RESMED INC. Currently has a direct ownership of 76,721 shares of RSMDF, which is worth approximately $0. The most recent transaction as insider was on Dec 01, 2021, when has been sold 2,400 shares (ResMed Common Stock) at a price of $256.84 per share, resulting in proceeds of $616,416. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 76.7K

0% 3M change

0% 12M change

Total Value Held $0

James Hollingshead Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 01 2021	SELL Open market or private sale	$616,416 $256.84 p/Share	2,400 Reduced 3.03%	76,721 ResMed Common Stock
Nov 18 2021	BUY Grant, award, or other acquisition	-	1,709 Added 2.11%	79,121 ResMed Common Stock
Nov 17 2021	SELL Payment of exercise price or tax liability	$3,073,009 $254.81 p/Share	12,060 Reduced 13.48%	77,412 ResMed Common Stock
Nov 16 2021	BUY Grant, award, or other acquisition	$5,187,932 $254.81 p/Share	20,360 Added 18.54%	89,472 ResMed Common Stock
Nov 11 2021	SELL Payment of exercise price or tax liability	$1,063,827 $259.47 p/Share	4,100 Reduced 5.6%	69,112 ResMed Common Stock
Nov 01 2021	SELL Open market or private sale	$634,440 $264.35 p/Share	2,400 Reduced 3.18%	73,177 ResMed Common Stock
Oct 08 2021	SELL Payment of exercise price or tax liability	$57,686 $246.52 p/Share	234 Reduced 0.31%	75,577 ResMed Common Stock
Oct 01 2021	SELL Open market or private sale	$627,192 $261.33 p/Share	2,400 Reduced 3.12%	74,479 ResMed Common Stock
Sep 01 2021	SELL Open market or private sale	$689,520 $287.3 p/Share	2,400 Reduced 3.03%	76,879 ResMed Common Stock
Aug 19 2021	BUY Grant, award, or other acquisition	-	5,741 Added 6.75%	79,279 ResMed Common Stock
Aug 02 2021	SELL Open market or private sale	$645,456 $268.94 p/Share	2,400 Reduced 3.16%	73,538 ResMed Common Stock
Jul 01 2021	SELL Open market or private sale	$593,520 $247.3 p/Share	2,400 Reduced 3.06%	75,938 ResMed Common Stock
Jun 01 2021	SELL Open market or private sale	$494,472 $206.03 p/Share	2,400 Reduced 2.97%	78,338 ResMed Common Stock
May 21 2021	SELL Open market or private sale	$484,824 $202.01 p/Share	2,400 Reduced 2.89%	80,738 ResMed Common Stock
Apr 12 2021	SELL Open market or private sale	$960,000 $200.0 p/Share	4,800 Reduced 5.46%	83,046 ResMed Common Stock
Feb 01 2021	SELL Open market or private sale	$480,432 $200.18 p/Share	2,400 Reduced 2.66%	87,846 ResMed Common Stock
Jan 18 2021	BUY Grant, award, or other acquisition	-	1,913 Added 2.08%	90,246 ResMed Common Stock
Jan 04 2021	SELL Open market or private sale	$506,616 $211.09 p/Share	2,400 Reduced 2.65%	88,333 ResMed Common Stock
Dec 01 2020	SELL Open market or private sale	$506,328 $210.97 p/Share	2,400 Reduced 2.58%	90,733 ResMed Common Stock
Nov 17 2020	SELL Payment of exercise price or tax liability	$3,338,563 $214.74 p/Share	15,547 Reduced 14.31%	93,133 ResMed Common Stock
Nov 17 2020	BUY Grant, award, or other acquisition	$5,636,066 $214.74 p/Share	26,246 Added 19.45%	108,680 ResMed Common Stock
Nov 11 2020	SELL Payment of exercise price or tax liability	$1,108,275 $212.11 p/Share	5,225 Reduced 5.96%	82,434 ResMed Common Stock
Nov 02 2020	SELL Open market or private sale	$468,000 $195.0 p/Share	2,400 Reduced 2.67%	87,602 ResMed Common Stock
Oct 01 2020	SELL Open market or private sale	$409,032 $170.43 p/Share	2,400 Reduced 2.6%	90,002 ResMed Common Stock

Also insider at

PODD

INSULET CORP Healthcare

President and CEO